Travis Richardson, MD
Cardiovascular Disease · Nashville, TNNPI 1558687806
Payments from drug & device makers
Across 361 payments — averaging $3523.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$912K
- Boston Scientific$169K
- Abbott$163K
- Biosense Webster, Inc.$22K
- Adagio Medical, Inc.$3K
- Philips North America LLC$2K
- plus $858 from 3 others
What the payments were for
- Consulting fees$35,42841%
- Speaking & faculty fees$19,87623%
- Grants$2,3953%
- Travel & lodging$20,72324%
- Food & beverage$8,71610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 205 | $911,735 |
| Boston Scientific | 63 | $168,932 |
| Abbott | 39 | $163,397 |
| Biosense Webster, Inc. | 40 | $22,322 |
| Adagio Medical, Inc. | 3 | $2,612 |
| Philips North America LLC | 3 | $2,098 |
| Altathera Pharmaceuticals LLC | 1 | $600 |
| Atricure, Inc. | 5 | $175 |
| Biotronik Inc. | 2 | $83 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$18,158
- Farapulse$5,932
- Micra$5,148
- IVUS Systems$1,880
- GENERAL BRADY$1,250
- Watchman$1,145
- EVERA MRI XT DR SURESCAN$1,036
- RHYTHMIA$961
- GENERAL - THERAPIES$889
- Rhythmia Mapping System$817
- AVEIR$753
- Sotalol Hydrochloride$600
- COBALT DR MRI SURESCAN$418
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$333
- AURORA EV-ICD MRI SURESCAN$284
- AMPLATZER AMULET$279
- AZURE XT DR MRI SURESCAN$231
- ENSITE$217
- ARCTIC FRONT ADVANCE$153
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$139
How this compares
$1,271,953 in reported general payments places this provider in the 95th percentile of 429 cardiovascular disease providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 459 | $569,634 |
| XareltoRivaroxaban | 44 | $45,426 |
| Dofetilide | 15 | $7,709 |
| FarxigaDapagliflozin Propanediol | 12 | $4,932 |
| Metoprolol Succinate | 245 | $4,394 |
| Propafenone Hcl ErPropafenone Hcl | 19 | $3,307 |
| Amiodarone Hcl | 121 | $2,447 |
| Flecainide Acetate | 62 | $2,404 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 51 | $1,227 |
| SotalolSotalol Hcl | 61 | $1,202 |
| Mexiletine Hcl | 12 | $1,151 |
| Metoprolol Tartrate | 69 | $643 |
| Atorvastatin Calcium | 34 | $422 |
| Losartan Potassium | 21 | $342 |
| Furosemide | 41 | $282 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Nashville
- Brian LindmanNashville$5.5M
- Christopher EllisNashville$4.1M
- Dinesh GuptaNashville$3.2M
- Joann LindenfeldNashville$2.2M
- Rebecca HungNashville$1.8M
- Mark ZenkerNashville$992K
- Arvindh KanagasundramNashville$912K
- Sandip ZalawadiyaNashville$647K
- Pete FongNashville$621K
- Macrae LintonNashville$572K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.